cdmo.directory
← Home
National Resilience logo

National Resilience

End-to-end CDMO for complex cell, gene, and RNA therapies across North America

Listed on cdmo.directory

End-to-end CDMO specializing in complex modalities including cell, gene, and RNA-based therapies with North American manufacturing facilities and development capabilities. Headquartered in Blue Ash, United States.

Modalities

Development & manufacturing

Structured CDMO capabilities from verified public sources.

Biologics / bioreactor infrastructure

Expression systems
MammalianMicrobial

Services

About this organization

National Resilience is a biomanufacturing CDMO focused on improving access to complex medicines through end-to-end solutions for safe and scalable biologics manufacturing. The company operates a network of high-tech facilities across North America designed to advance complex modalities with leading-edge development and manufacturing capabilities.

Core Capabilities:

  • Cell, gene, and RNA-based therapy manufacturing
  • Fill/finish manufacturing and timeline acceleration
  • Drug substance to drug product manufacturing
  • Vaccine manufacturing (including aluminum adjuvant formulations)
  • Development and manufacturing services from concept to commercialization

Approach: Resilient supply chain design with minimal disruption; stage-gate development models; focus on speed, quality, and scalability for advanced therapeutics.

Certifications

AuthorityIdentifierSource
FDAcGMPView
FDAPAIView
FDAPFS & Vial ApprovalView
Health CanadaHealth CanadaView
EMAVirtual InspectionView

Locations

  • Headquarters

    Blue Ash · OH · USA

  • Cincinnati

    Cincinnati · OH · USA

  • Philadelphia

    Philadelphia · PA · USA

  • Toronto

    Toronto · ON · Canada

  • Fremont

    Fremont · California · United States

Submit a verified review for this organization.

Markdown mirror: /companies/resilience.md